US Asks Justices To Skip Challenge To IRS Drug Probe Power
The U.S. Supreme Court should not review a medical marijuana company's claims it was improperly denied over $50,000 in business deductions because it has already rejected the argument that the IRS lacks...To view the full article, register now.
Already a subscriber? Click here to view full article